Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK(2)R Cancer Theranostic Agents: A Preclinical Study

(1) Background: Theranostic approaches in the management of cholecystokinin subtype 2 receptor (CCK(2)R)-positive tumors include radiolabeled gastrin and CCK motifs. Moving toward antagonist-based CCK(2)R-radioligands instead, we herein present three analogs of the nonpeptidic CCK(2)R-antagonist Z36...

Descripción completa

Detalles Bibliográficos
Autores principales: Nock, Berthold A., Kanellopoulos, Panagiotis, Chepurny, Oleg G., Rouchota, Maritina, Loudos, George, Holz, George G., Krenning, Eric P., Maina, Theodosia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954547/
https://www.ncbi.nlm.nih.gov/pubmed/35336041
http://dx.doi.org/10.3390/pharmaceutics14030666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954547/
https://www.ncbi.nlm.nih.gov/pubmed/35336041
http://dx.doi.org/10.3390/pharmaceutics14030666

Ejemplares similares